title: [Eye toxicity of antimalarial agents].
abstract: We relate the evolution of a patient with Systemic Lupus Erythematosus with mucocutaneous, hematological, joint and renal expression. The skin lesions were treated with Chloroquine and Hydroxychloroquine and severe ocular toxicity related with antimalarials agent was developed. We revised the antimalarials use in Rheumatology, their utility, doses, adverse events and risk factors as cumulate doses, ideal daily doses, renal function and ophthalmological reviews recommendations.
authors.affiliation: Servicio de Reumatología, Complejo Hospitalario Juan Canalejo, Xubias de Arriba, 84, 15006 A Coruña.
authors.forename: J
authors.initials: J
authors.lastname: Graña Gil
authors.forename: M
authors.initials: M
authors.lastname: Cabana Vázquez
authors.forename: A
authors.initials: A
authors.lastname: Vázquez González
authors.forename: M O
authors.initials: MO
authors.lastname: Sánchez Meizoso
mesh_terms: D000328:Adult; D000962:Antimalarials / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects*; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*
chemical_list: D000962:Antimalarials; D006886:Hydroxychloroquine; D002738:Chloroquine